Philosophy
HOME / MANUFACTURING / PHYLOSOPHY
Philosophy
HOME / MANUFACTURING / PHYLOSOPHY
In the recent past most pharmaceutical companies had a large number of factories scattered all over the world.
More recently, production plants have been significantly reorganised and concentrated as the result of:
- Increased pressure on costs
- Governments may be less able to subsidise investments of mid-size companies
- Merger / acquisition activities
- New, strict GMP rules
- Focus on other core activities (Business Development e Production)
Consequently, pharmaceutical companies are concentrating their manufacturing efforts on their core products and new technologies Major opportunities are being offered for the outsourcing of:
- Classical Manufacturing
- High Class Generics (2010)
- Generics / Supergenerics Production
- Niches where heavy capital investment can be avoided
- Third-party manufacturers will be successful when located in countries where outstanding pharmaceutical skills are available together with flexibility, creativity and a customer-oriented service culture. Northern Italy fits this picture perfectly.
Focus on Technology / Innovation
Manufacturing
- State-of-the-art site
- FDA approval
- Special production
- New technical strategy (Lean + IQP)
Development / Special Services
- Using new technological platforms
- Supergenerics
LEARN MORE
For any information you can contact our staff calling us, sending us an email or using the form in the Contact page.